Skip to main content
Fig. 3 | The Journal of Headache and Pain

Fig. 3

From: Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control study

Fig. 3

Box plots of the temporospatial profile of CX3CL1. The median and IQR of CX3CL1 concentration in pg/ml in serum and CSF of the 3 different cohorts are presented. A significant difference was found in the amount of CX3CL1 in the cerebrospinal fluid (CSF) between the sample of migraine patients who had an ictal headache and the control group and of migraine patients who did not have an ictal headache. Right: ROC curve analysis of CX3CL1 between migraine patients (ictally and interictally collected samples) and healthy controls, AUC of 0.699 (95% CI 0,563 to 0,813, p = 0.007)

Back to article page